Thalidomide leads to mandible hypoplasia through inhibiting angiogenesis and secondary hemorrhage in the fetal craniofacial region in rabbits.
Toxicol Lett
; 319: 250-255, 2020 Feb 01.
Article
en En
| MEDLINE
| ID: mdl-31778774
ABSTRACT
The effect of thalidomide on mandibular development is unclear. In this study, thalidomide was delivered to pregnant rabbits from the 8th to 14th day of gestation. Then, embryos were harvested for examination on the 16th day (GD16), 20th day (GD20) and 24th day (GD24) of gestation. The results showed obvious hemorrhage and hematoma on one side of the craniofacial region in 50 % of the thalidomide-treated embryos and obvious hemorrhage and hematoma on both sides of the craniofacial region in 50 % of the thalidomide-treated embryos at GD16. Histological examination showed soft tissues and mandible defects on the affected side of the maxillofacial region. The expression of Vegf-α, Ki67 and Sox9 on the affected side was significantly down-regulated in comparison to their expression on the unaffected side at GD20. There was also an obvious defect in the affected mandible, and the density of the skull and mandible was decreased compared to the unaffected side or the control group at GD24. These findings demonstrated that thalidomide may lead to hemorrhage and hematoma in the craniofacial region by inhibiting angiogenesis, resulting in the abnormal development of cranial neural crest cells that are involved in the normal development of the mandible in rabbits.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Teratógenos
/
Talidomida
/
Neovascularización Fisiológica
/
Anomalías Craneofaciales
/
Hemorragia
/
Mandíbula
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Toxicol Lett
Año:
2020
Tipo del documento:
Article